<DOC>
	<DOC>NCT01436513</DOC>
	<brief_summary>The purpose of this study is to assess the bioequivalence and food effect for a new Premarin formulation compared with a Premarin reference tablet in Japanese healthy postmenopausal women.</brief_summary>
	<brief_title>A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions.</brief_title>
	<detailed_description />
	<mesh_term>Vaginitis</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Metrorrhagia</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Estrogens, Conjugated (USP)</mesh_term>
	<criteria>Japanese healthy postmenopausal women History or current evidence of thrombophlebitis, thromboembolic disorders, or any coagulopathies. History or presence of malignancy or estrogendependent neoplasia. Subjects with a documented history of any malignancy, except for basal or squamous cell carcinoma of skin, which has been treated and fully resolved for a minimal 5 years. History or presence of benign or malignant liver tumor that developed during the use of oral contraceptives or other estrogencontaining products.</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>bioequivalence</keyword>
	<keyword>menometrorrhagia</keyword>
	<keyword>climacteric disturbance</keyword>
	<keyword>Estrogen Replacement Therapy</keyword>
	<keyword>Estrogens Conjugated</keyword>
</DOC>